Public office holders should not engage in corruption – HH

By Prince Mabumba

PRESIDENT Hakainde Hichilema has urged those who are holding public offices to safeguard public resources from abuse.

The head of state says, doing so will help to achieve the desired development.

President Hichilema said, ministers, permanent secretaries and district commissioners should desist from squandering public resources so that Zambians can benefit.

He says, he will ensure that the fight against corruption is enhanced for the betterment of the country.

President Hichilema was speaking in Chingola when he met the clergy.

And Mr Hichilema has assured Zambians that the farming inputs for the 2023-2024 farming season will be delivered on time.

New smoking cessation intervention helps patients with cervical cancer precursor or cervical cancer quit smoking

Tobacco use is the leading preventable cause of death in the U.S., accounting for about 1 in 5 deaths each year. It is also a risk factor for the development of cervical cancer and precancerous stages of cervical cancer. It is important to identify approaches to encourage people to quit smoking to prevent the development of cancer and improve patient outcomes in those who do smoke.

Food security: New tool can forecast food insecurity up to 30 days in advance

A new tool that can be used to forecast the prevalence of individuals within a country that may have insufficient access to food—known as food insecurity—up to 30 days into the future is presented in a study published in Scientific Reports. The authors suggest that the tool could aid decision makers in countries at risk of food insecurity and help facilitate more timely responses.

Genetic causes of three previously unexplained rare diseases identified

Using a new computational approach they developed to analyze large genetic datasets from rare disease cohorts, researchers at the Icahn School of Medicine at Mount Sinai and colleagues have discovered previously unknown genetic causes of three rare conditions: primary lymphedema (characterized by tissue swelling), thoracic aortic aneurysm disease, and congenital deafness.

Dual immunotherapy plus chemotherapy before surgery improves patient outcomes in operable lung cancer

In a Phase II trial led by researchers from The University of Texas MD Anderson Cancer Center, adding ipilimumab to a neoadjuvant, or pre-surgical, combination of nivolumab plus platinum-based chemotherapy, resulted in a major pathologic response (MPR) in half of all treated patients with early-stage, resectable non-small cell lung cancer (NSCLC).

Study of immune ‘neighborhoods’ highlights macrophages as key players in invasive breast cancers

Most immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targeting a different type of immune cell called macrophages could be a more effective approach, suggests a comprehensive new analysis of invasive ER+ breast cancers led by University of Pittsburgh School of Medicine scientists.